Form D · Private Equity Fund

MPM BioVentures 2022, L.P.

Boston, MA · CIK 0001921656

Offering snapshot reported Jun 1, 2023 · SEC filing

Reported sold: $351M
Investors reported: 45
Minimum accepted: $0
First sale: May 26, 2022

What changed?

Latest filing versus its linked predecessor, where available.

Reported investors0 → 45

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Jun 1, 2023	Amendment	$351,010,000	No comparison	45	SEC filing
May 5, 2022	Initial	Yet to sell	No comparison	0	SEC filing

Offering details

Securities: Pooled investment fund
Exemptions: 06b, 3C, 3C.7
Duration over one year: Yes
Business combination: No

Sales commissions: $1.05M
Finders' fees: $0
Form D file number: 021-444554

Sales compensation recipients

Scroll to see all columns →

Recipient	CRD	Associated broker-dealer
J.P. MORGAN SECURITIES LLC	79

Source: Form D, filed Jun 1, 2023. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

MPM BIOVENTURES 2022, L.P.

Investment adviser: MPM ASSET MANAGEMENT LLC

Gross asset value: $351M
Beneficial owners: 47
ADV minimum commitment: $3M

Reported in Form ADV on Apr 28, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator STANDISH MANAGEMENT, LLC SAN FRANCISCO, California, United States Investor statements: Yes (provided to all investors) Related to adviser: No

Auditor KPMG BOSTON, Massachusetts, United States

Custodian J.P. MORGAN SECURITIES LLC BOSTON, Massachusetts, United States Related to adviser: No

Custodian SILICON VALLEY BANK NEWTON, Massachusetts, United States Related to adviser: No

Provider details

Annual audit: Yes
Prime brokers: No
Custodians: Yes
Administrator other than the adviser: Yes
External marketing: No

KPMG
PCAOB 185

J.P. MORGAN SECURITIES LLC
SEC 8-35008

SILICON VALLEY BANK
LEI 549300A7DTSCJLJ33451

Filing source

Form ADV 2098941 · Apr 28, 2026 · Schedule D 7.B.(1), fund 805-1480238338

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Luke Evnin	Executive
Ansbert Gadicke	Executive
N/A Mpm Bioventures 2022 Gp Llc	Promoter

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:

399 Boylston Street, Suite 1100
Boston, MA, 02116